-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Telesis Bio Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
- Telesis Bio Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $2 K, a 33.3% decline year-over-year.
- Telesis Bio Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $23 K, a 9.52% increase year-over-year.
- Telesis Bio Inc. annual Income Tax Expense (Benefit) for 2023 was $24 K, unchanged from 2022.
- Telesis Bio Inc. annual Income Tax Expense (Benefit) for 2022 was $24 K, a 71.4% increase from 2021.
- Telesis Bio Inc. annual Income Tax Expense (Benefit) for 2021 was $14 K, a 180% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual Data (USD)